Sotatercept for treating pulmonary arterial hypertension [ID6163]

  • In development
  • GID-TA11103
  • Expected publication date: TBC

NICE has paused the evaluation of sotatercept for treating pulmonary arterial hypertension [ID6163] because the company and NHSE have commenced commercial discussions.

Please note that following on from advice received from the company this appraisal has been rescheduled to align with latest regulatory expectations, and further details regarding timings and how you can get involved will be available in due course.